These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1335217)

  • 1. A placebo-controlled trial of buspirone in anxious inpatient alcoholics.
    Malcolm R; Anton RF; Randall CL; Johnston A; Brady K; Thevos A
    Alcohol Clin Exp Res; 1992 Dec; 16(6):1007-13. PubMed ID: 1335217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.
    Malec E; Malec T; Gagné MA; Dongier M
    Alcohol Clin Exp Res; 1996 Apr; 20(2):307-12. PubMed ID: 8730222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone treatment of anxious alcoholics. A placebo-controlled trial.
    Kranzler HR; Burleson JA; Del Boca FK; Babor TF; Korner P; Brown J; Bohn MJ
    Arch Gen Psychiatry; 1994 Sep; 51(9):720-31. PubMed ID: 8080349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone in the treatment of alcoholic patients.
    Bruno F
    Psychopathology; 1989; 22 Suppl 1():49-59. PubMed ID: 2657838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of buspirone in alcohol dependence: a review.
    Malec TS; Malec EA; Dongier M
    Alcohol Clin Exp Res; 1996 Aug; 20(5):853-8. PubMed ID: 8865960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).
    Tollefson GD; Montague-Clouse J; Tollefson SL
    J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
    Tollefson GD; Lancaster SP; Montague-Clouse J
    Psychopharmacol Bull; 1991; 27(2):163-70. PubMed ID: 1924664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD; Udelman DL
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluoxetine on alcohol consumption in male alcoholics.
    Gorelick DA; Paredes A
    Alcohol Clin Exp Res; 1992 Apr; 16(2):261-5. PubMed ID: 1317133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.
    van Vliet IM; den Boer JA; Westenberg HG; Pian KL
    J Clin Psychiatry; 1997 Apr; 58(4):164-8. PubMed ID: 9164427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse among alcoholics with phobic and panic symptoms.
    LaBounty LP; Hatsukami D; Morgan SF; Nelson L
    Addict Behav; 1992; 17(1):9-15. PubMed ID: 1317660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.
    Fawcett J; Kravitz HM; McGuire M; Easton M; Ross J; Pisani V; Fogg LF; Clark D; Whitney M; Kravitz G; Javaid J; Teas G
    Alcohol Clin Exp Res; 2000 May; 24(5):666-74. PubMed ID: 10832908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone.
    Feighner JP; Cohn JB
    Neuropsychobiology; 1989; 21(3):124-30. PubMed ID: 2615929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.